510(k) K033982

MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST by Vysis — Product Code MMW

K033982 is an FDA 510(k) premarket notification submitted by Vysis for the device "MODIFICATION TO VYSIS UROVYSION BLADDER CANCER RECURRENCE TEST". The FDA issued a decision of Substantially Equivalent on Jan 22, 2004. The device falls under product code MMW (System, Test, Tumor Marker, Monitoring, Bladder), a Class II device regulated under 21 CFR 866.6010. Vysis has 8 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 22, 2004
Date Received
Dec 23, 2003
Clearance Type
Special
Expedited Review
No
Third Party Review
No

Device classification

Device Name
System, Test, Tumor Marker, Monitoring, Bladder
Device Class
Class II
Regulation Number
866.6010
Review Panel
IM
Submission Type
510(k)

Need the full FDA record for Vysis? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K033982. Report a data issue: hello@regdatalab.com.